Stock Events

Stock Events

Xeris Biopharma (XERS) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.11

-0.08

-0.04

-0.01

Details

Expected EPS

-0.028

Actual EPS

-0.01

Surprise EPS

0.02

Surprise Percent

+64.29%

Description

Xeris Biopharma (XERS) has reported earnings of -0.01 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.